BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19801154)

  • 1. Brain dysfunction in multiple chemical sensitivity.
    Orriols R; Costa R; Cuberas G; Jacas C; Castell J; Sunyer J
    J Neurol Sci; 2009 Dec; 287(1-2):72-8. PubMed ID: 19801154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Subcortical Brain Structures During Olfactory Stimulation in Multiple Chemical Sensitivity.
    Alessandrini M; Micarelli A; Chiaravalloti A; Bruno E; Danieli R; Pierantozzi M; Genovesi G; Öberg J; Pagani M; Schillaci O
    Brain Topogr; 2016 Mar; 29(2):243-52. PubMed ID: 26438099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive neuroactivation using SPECT and the Stroop Colored Word Test in patients with diffuse brain injury.
    Goethals I; Audenaert K; Jacobs F; Lannoo E; Van de Wiele C; Ham H; Otte A; Oostra K; Dierckx R
    J Neurotrauma; 2004 Aug; 21(8):1059-69. PubMed ID: 15319005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.
    Nobili F; Abbruzzese G; Morbelli S; Marchese R; Girtler N; Dessi B; Brugnolo A; Canepa C; Drosos GC; Sambuceti G; Rodriguez G
    Mov Disord; 2009 Feb; 24(3):414-21. PubMed ID: 19235928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Odor processing in multiple chemical sensitivity.
    Hillert L; Musabasic V; Berglund H; Ciumas C; Savic I
    Hum Brain Mapp; 2007 Mar; 28(3):172-82. PubMed ID: 16767766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: a correlation with neuropsychological tests.
    Chang CC; Liu JS; Chang YY; Chang WN; Chen SS; Lee CH
    Eur J Neurol; 2008 Jan; 15(1):61-5. PubMed ID: 18042240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional cerebral perfusion abnormalities in attention deficit/hyperactivity disorder. Statistical parametric mapping analysis.
    Kim BN; Lee JS; Shin MS; Cho SC; Lee DS
    Eur Arch Psychiatry Clin Neurosci; 2002 Oct; 252(5):219-25. PubMed ID: 12451463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic brain hypoperfusion due to multi-vessel extracranial atherosclerotic disease: a potentially reversible cause of cognitive impairment.
    Safouris A; Hambye AS; Sculier C; Papageorgiou SG; Vasdekis SN; Gazagnes MD; Tsivgoulis G
    J Alzheimers Dis; 2015; 43(1):23-7. PubMed ID: 25061057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurophysiological correlates of metabolic syndrome and cognitive impairment in schizophrenia: a structural equation modeling approach.
    Boyer L; Testart J; Michel P; Richieri R; Faget-Agius C; Vanoye V; Auquier P; Lancon C; Guedj E
    Psychoneuroendocrinology; 2014 Dec; 50():95-105. PubMed ID: 25199983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of cognition and regional cerebral activity during acute hypoglycemia in normal subjects: A H2 15O positron emission tomographic study.
    Bie-Olsen LG; Kjaer TW; Pedersen-Bjergaard U; Lonsdale MN; Holst JJ; Law I; Thorsteinsson B
    J Neurosci Res; 2009 Jun; 87(8):1922-8. PubMed ID: 19170163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reversed clock drawing test phenomenon in Alzheimer's disease: A perfusion SPECT study.
    Brugnolo A; Morbelli S; Dessi B; Girtler N; Mazzei D; Famà F; Barbieri P; Cabassi G; Koulibaly PM; Sambuceti G; Rodriguez G; Nobili F
    Dement Geriatr Cogn Disord; 2010; 29(1):1-10. PubMed ID: 20093833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple chemical sensitivity: a test of the olfactory-limbic model.
    Brown-DeGagne AM; McGlone J
    J Occup Environ Med; 1999 May; 41(5):366-77. PubMed ID: 10337606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of antihypertensive therapy on cerebral perfusion in patients with metabolic syndrome: relationship with cognitive function and 24-h arterial blood pressure monitoring.
    Efimova NY; Chernov VI; Efimova IY; Lishmanov YB
    Cardiovasc Ther; 2015 Aug; 33(4):209-15. PubMed ID: 25988865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurospect in neurotoxic chemical exposure demonstration of long-term functional abnormalities.
    Heuser G; Mena I
    Toxicol Ind Health; 1998; 14(6):813-27. PubMed ID: 9891913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebral blood flow in patients with various symptoms of hemispatial neglect following ischemic stroke].
    Jodzio K; Gasecki D; Nyka W; Lass P
    Neurol Neurochir Pol; 2004; 38(5):381-8. PubMed ID: 15565524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson's disease--a rCBF scintigraphy study.
    Wallin A; Ekberg S; Lind K; Milos V; Granérus AK; Granerus G
    Acta Neurol Scand; 2007 Dec; 116(6):347-54. PubMed ID: 17927803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Odor Thresholds and Responses in Cerebral Blood Flow of the Prefrontal Area during Olfactory Stimulation in Patients with Multiple Chemical Sensitivity.
    Azuma K; Uchiyama I; Tanigawa M; Bamba I; Azuma M; Takano H; Yoshikawa T; Sakabe K
    PLoS One; 2016; 11(12):e0168006. PubMed ID: 27936122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicity in single photon emission computed tomography brain scans of patients reporting chemical sensitivities.
    Ross GH; Rea WJ; Johnson AR; Hickey DC; Simon TR
    Toxicol Ind Health; 1999; 15(3-4):415-20. PubMed ID: 10416294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.